Previous 10 | Next 10 |
2024-03-15 10:06:29 ET More on Geron Geron: Advisory Nod Boosts Approval Odds, But Market Position Remains Hazy Geron Post 2023 Earnings - Gearing Up For Critical Imetelstat AdCom, PDUFA Geron Corporation (GERN) Q4 2023 Earnings Call Transcript Geron wins FDA...
A look at the top 10 most actives in the United States Grab Holdings Limited (GRAB) fell 0.2% to $3.235 on volume of 103,635,000 shares Better Therapeutics Inc. (BTTX) rose 108.6% to $0.073 on volume of 98,804,254 shares Verb Technology Company Inc. (VERB) rose 156.3% to $0.3639 on volume...
2024-03-15 09:34:33 ET DENVER, Colo., Mar 15, 2024 ( 247marketnews.com )- Geron Corporation (NASDAQ: GERN ) announced that the FDA’s Oncologic Drugs Advisory Committee (ODAC) voted 12 to 2 in favor of the clinical benefit/risk profile of imetelstat, based on results from the ...
2024-03-15 08:59:41 ET Summary Geron's valuation may overestimate imetelstat's market impact for MDS, given FDA's moderate enthusiasm and efficacy concerns. FDA concerns include imetelstat's marginal efficacy, safety issues, and a non-significant improvement in patient outcomes. ...
2024-03-15 05:45:23 ET More on related stocks: Adobe Inc. (ADBE) Q1 2024 Earnings Call Transcript Ulta Beauty, Inc. (ULTA) Q4 2023 Earnings Call Transcript Adobe Earnings: 3 Key Areas To Focus On With The Release Adobe in charts: Digital media revenue climbs ...
FDA Oncologic Drugs Advisory Committee voted 12 to 2 in favor of the clinical benefit/risk profile of imetelstat based on results from the IMerge Phase 3 clinical trial There are significant unmet needs across key TD LR-MDS patient populations, including difficult-to-treat subgroups that are ...
2024-03-14 15:39:52 ET More on Geron Geron Post 2023 Earnings - Gearing Up For Critical Imetelstat AdCom, PDUFA Geron Corporation (GERN) Q4 2023 Earnings Call Transcript Geron's Ideal Situation Appears To Be Already Priced In Geron slips as FDA reviews blood ...
2024-03-12 11:00:48 ET More on Geron Geron Post 2023 Earnings - Gearing Up For Critical Imetelstat AdCom, PDUFA Geron Corporation (GERN) Q4 2023 Earnings Call Transcript Geron's Ideal Situation Appears To Be Already Priced In Seeking Alpha’s Quant Rati...
2024-03-10 13:08:00 ET More on ALX Oncology, Bicycle Therapeutics, etc. Immunocore Holdings plc (IMCR) Q4 2023 Earnings Call Transcript Kura Oncology, Inc. (KURA) Q4 2023 Earnings Call Transcript Kura Oncology, Inc. 2023 Q4 - Results - Earnings Call Presentation ...
2024-03-05 10:30:29 ET Summary Geron Corporation's lead candidate, imetelstat, is awaiting FDA approval for the treatment of transfusion-dependent anemia in adult patients with low-to-intermediate-1 risk myelodysplastic syndromes. The company reported a loss from operations of $19...
News, Short Squeeze, Breakout and More Instantly...
U.S. stocks were higher, with the Dow Jones jumping over 150 points on Friday. Shares of Skechers U.S.A., Inc. (NYSE:SKX) rose sharply during Frida...
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that it will release its first quarter 2024 financial results and business highlights before the market opens on Thursday, May 2, 2024 via press release, which will be available on the Companyȁ...
U.S. stocks were lower, with the Dow Jones index falling over 250 points on Friday. Shares of Argan, Inc. (NYSE: AGX) rose sharply during Friday&r...